Stay updated on Intranasal Vasopressin in Autism Children Clinical Trial
Sign up to get notified when there's something new on the Intranasal Vasopressin in Autism Children Clinical Trial page.

Latest updates to the Intranasal Vasopressin in Autism Children Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed information about a clinical trial investigating vasopressin nasal spray for autism, while retaining the names of key collaborators and investigators.SummaryDifference21%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check59 days agoChange DetectedThe page now includes a new certification/extension date, indicating that the certification was first submitted on March 14, 2025.SummaryDifference0.2%
- Check81 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Intranasal Vasopressin in Autism Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Vasopressin in Autism Children Clinical Trial page.